Tiotropium and olodaterol exert anti-proliferative effects on pulmonary fibroblasts of asthmatic patients in vitro

L. Costa, M. Roth, M. Tamm, P. Borger (Basel, Switzerland)

Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Session: Airway smooth muscle and cell biology
Session type: Thematic Poster Session
Number: 571
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Costa, M. Roth, M. Tamm, P. Borger (Basel, Switzerland). Tiotropium and olodaterol exert anti-proliferative effects on pulmonary fibroblasts of asthmatic patients in vitro. Eur Respir J 2013; 42: Suppl. 57, 571

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The mechanisms of anti-inflammatory action of bronchodilators
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013

Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015


Enhanced anti-inflammatory gene expression in humans following inhaled budesonide
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013

T regulatory cells: Immunomodulation by budesonide and formoterol on COPD patients
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015

Differential effects of budesonide and fluticasone propionate on bronchial epithelial barrier function
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014

Pro-and anti-fibrotic molecule balance in the bronchial mucosa of stable COPD patients
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015

Inhibitory effects of montelukast on mediator release by nasal epithelial cells from asthmatic subjects
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013


An antedrug of the CXCL12 neutraligand blocks experimental allergic asthma without systemic effect in the mouse
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013

Differential effects of budesonide and fluticasone propionate on expression of lactotransferrin in airway epithelium
Source: International Congress 2014 – Novel evidence relating to respiratory treatment development
Year: 2014

Inhibitors of apoptosis proteins in asthmatic airway inflammation
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013


Additive anti-inflammatory effect of glucocorticoids and PDE4 inhibitors on COPD CD8 cells
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014

Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014

Effect of roflumilast on airway remodeling in a murine model of chronic asthma
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015


Differential effect of fluticasone on Poly(I:C) induced TSLP secretion by bronchial epithelial cells from asthmatic children
Source: International Congress 2016 – Mechanisms of disease
Year: 2016

The effect of the inhaled PDE4 inhibitor CHF6001 on allergen-induced inflammation in asthmatics
Source: International Congress 2014 – Asthma and COPD management
Year: 2014

Anti-inflammatory effects of resveratrol analogues in cellular models of airway inflammation
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015

IL-17A is elevated in patients with COPD and contributes to airway remodeling by acting on fibroblasts
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016

Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015

The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway
Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases
Year: 2014

Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014